机构：[1]Institute of Mental Health, Peking University Sixth Hospital, Beijing 100191,China[2]National Clinical Research Center for Mental Disorders, Peking Uni‑versity Sixth Hospital, Beijing 100191, China[3]NHC Key Laboratory of MentalHealth and Research Unit of Diagnosis and Treatment of Mood CognitiveDisorder (2018RU006), Chinese Academy of Medical Sciences, Beijing 100191,China[4]Peking University Huilongguan Clinical Medical School, BeijingHuilongguan Hospital, Beijing 100096, China[5]Department of Psychiatry,Jining Medical University, Jining 272067, Shandong, China[6]Henan Key Labof Biological Psychiatry, The Second Afliated Hospital of Xinxiang Medi‑cal University, Xinxiang 435001, Henan, China[7]Key Laboratory of AnimalModels and Human Disease Mechanisms of the Chinese Academy of Sci‑ences and Yunnan Province, Kunming Institute of Zoology, Chinese Academyof Sciences, Kunming 650223, China[8]Institute of Psychiatry, Psychologyand Neuroscience, King’s College London, London WC2R 2LS, UK[9]State KeyLaboratory of Cognitive Neuroscience and Learning, Beijing Normal University,Beijing 100875, China[10]Analytic and Translational Genetics Unit, Massachu‑setts General Hospital, Boston, MA 02114, USA[11]Stanley Center for PsychiatricResearch, The Broad Institute of MIT and Harvard, Cambridge, MA 02141,USA[12]Department of Medicine, Harvard Medical School, Boston, MA 02115,USA[13]Department of Biostatistics and Computational Biology, School of Life Sciences, Fudan University, Shanghai 200438, China[14]Department of Neurol‑ogy, Xuanwu Hospital, Capital Medical University, Beijing 100053, China首都医科大学宣武医院[15]State Key Laboratory of Natural and Biomimetic Drugs, Key Laboratoryfor Neuroscience for Ministry of Education, School of Pharmaceutical Sciences,Peking University Health Science Center, Beijing 100191, China[16]PKU‑IDG/McGovern Institute for Brain Research, Peking University, Beijing 100871,China[17]Chinese Institute for Brain Research, Beijing 102206, China
This work was supported by grants from the National Natural Science Founda‑
tion of China (81825009, 82071505, 81901358), the Chinese Academy of
Medical Sciences Innovation Fund for Medical Sciences (2021-I2M-C&T-B-099;
2019-I2M-5–006), the Program of Chinese Institute for Brain Research Beijing
(2020-NKX-XM-12), the King’s College London—Peking University Health Sci‑
ence Center Joint Institute for Medical Research (BMU2020KCL001, BMU2019L‑
CKXJ012), and the National Key R&D Program of China (2021YFF1201103,
2016YFC1307000).
第一作者机构：[1]Institute of Mental Health, Peking University Sixth Hospital, Beijing 100191,China[2]National Clinical Research Center for Mental Disorders, Peking Uni‑versity Sixth Hospital, Beijing 100191, China[3]NHC Key Laboratory of MentalHealth and Research Unit of Diagnosis and Treatment of Mood CognitiveDisorder (2018RU006), Chinese Academy of Medical Sciences, Beijing 100191,China
通讯作者：
通讯机构：[1]Institute of Mental Health, Peking University Sixth Hospital, Beijing 100191,China[2]National Clinical Research Center for Mental Disorders, Peking Uni‑versity Sixth Hospital, Beijing 100191, China[3]NHC Key Laboratory of MentalHealth and Research Unit of Diagnosis and Treatment of Mood CognitiveDisorder (2018RU006), Chinese Academy of Medical Sciences, Beijing 100191,China[16]PKU‑IDG/McGovern Institute for Brain Research, Peking University, Beijing 100871,China[17]Chinese Institute for Brain Research, Beijing 102206, China
推荐引用方式(GB/T 7714)：
Liang‑Kun Guo,Yi Su,Yu‑Ya‑Nan Zhang,et al.Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis[J].MILITARY MEDICAL RESEARCH.2023,10(1):doi:10.1186/s40779-023-00459-7.
APA：
Liang‑Kun Guo,Yi Su,Yu‑Ya‑Nan Zhang,Hao Yu,Zhe Lu...&Wei‑Hua Yue.(2023).Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis.MILITARY MEDICAL RESEARCH,10,(1)
MLA：
Liang‑Kun Guo,et al."Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis".MILITARY MEDICAL RESEARCH 10..1(2023)
医学